Skip to: Content | Navigation | Sub Navigation


Reviews of Photodisinfection/Photodynamic Therapy

  1. Hamblin MR, Hasan T (2004) Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochemical and Photobiological Sciences 3: 436-450.
  2. Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, Dei D, Fantetti L, Chiti G, Roncucci G (2006) Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers in Surgery and Medicine 38: 468-481.
  3. Tardivo J, Giglio A, Oliveira C, Gabrielli D, Junqueira H, Tada D, Severino D, Turchiello R, Baptista M (2005) Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagnosis and Photodynamic Therapy 2: 175-191.
  4. Maisch T, Hackbarth S, Regensburger J, Felgenträger A, Bäumler W, Landthaler M, Röder B (2010) Photodynamic inactivation of multi-resistant bacteria (PIB) – a new approach to treat superficial infections in the 21st century. Journal of the German Society of Dermatology 8: 1-7.

Photodisinfection for Eradication of MRSA

  1. Zolfaghari PS, Packer S, Singer M, Nair SP, Bennett J, Street C, Wilson M (2009) In vivo killing of Staphylococcus aureus using a light activated antimicrobial agent. BMC Microbiology 9: 27.
  2. Gil-Thomas J, Tubby S, Parkin IP, Narband N, Dekker L, Nair SP, Wilson M, Street CN (2007) Lethal photosensitization of Staphylococcus aureus using a toluidine blue-O-tiopronin-gold nanoparticle conjugate. Journal of Materials Chemistry 17: 3739-3746.
  3. Narband M, Tubby S, Parkin IP, Gil-Thomas J, Ready D, Nair SP, Wilson M (2008) Gold nanoparticles enhance the toluidine blue induced lethal photosensitization of Staphylococcus aureus. Current Nanoscience 4: 409-414.
  4. Wainwright M, Phoenix DA, Laycock SL, Wareing DR, Wright PA (1998) Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiology Letters 160: 177-181.
  5. Grinholc M, Szranka B, Kurlenda J, Graczyk A, Bielawski K (2008) Bactericidal effect of photodynamic inactivation against methicillin-resistant and methicillin-susceptible Staphylococcus aureus is strain dependent. Journal of Photochemistry and Photobiology B: Biology 90: 57-63.
  6. Maisch T, Baier J, Franz B, Maier M, Landthaler M, Szeimies RF, Baumler W (2007) The role of singlet oxygen and oxygen concentration in photodynamic inactivation of bacteria. Proceedings of the National Academy of Sciences 104(17): 7223-7228.
  7. Zeina B, Greenman J, Purcell WM, Das B (2001) Killing of cutaneous microbial species by photodynamic therapy. British Journal of Dermatology 144: 274-278.
  8. Embleton ML, Nair SP, Cookson BD, Wilson M (2002) Selective lethal photosensitization of methicillin-resistant Staphylococcus aureus using an IgG tin (IV) chlorine E6 conjugate. Journal of Antimicrobial Chemotherapy 50: 857-864.
  9. Lambrechts SA, Demidova TM, Aalders MC, Hasan T, Hamblin MR (2005) Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochemical and Photobiological Sciences 4: 503-509.
  10. Sharma M, Visai L, Bragheri F, Cristiani I, Gupta PK, Speziale P (2008) Toluidine blue mediated photodynamic effects on Staphylococcal biofilms. Antimicrobial Agents and Chemotherapy 52(1): 299-305.
  11. Omar GS, Wilson M, Nair SP (2008) Lethal photosensitization of wound associated microbes using indocyanine green and near infrared light. BMC Microbiology 8: 111.
  12. Maclean M, Macgregor SJ, Anderson JG, Woolsey GA (2008) The role of oxygen in the visible light inactivation of Staphylococcus aureus. Journal of Photochemistry and Photobiology B: Biology 92: 180-184.
  13. Street C, Pedigo L, Gibbs A, Loebel N (2009) Antimicrobial Photodynamic Therapy for the Decolonization of Methicillin-Resistant Staphylococcus aureus from the Anterior Nares. SPIE 7380(3B): 1-16.
  14. Tubby S, Wilson M and Nair SP (2009) Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent. BMC Microbiology 9: 211.

Nasal Colonization By Staphylococcus aureus/MRSA

  1. Nouwen JL, van Belkum A, Verbrugh HA (2001) Determinants of Staphylococcus aureus nasal carriage. The Netherlands Journal of Medicine 59: 126-133.
  2. von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteraemia. The New England Journal of Medicine 344(1): 11-16.
  3. Safdar N, Bradley E (2008) The risk of infection after nasal colonization with Staphylococcus aureus. The American Journal of Medicine 121: 310-315.
  4. Solberg CO (2000) Spread of Staphylococcus aureus in hospitals: Causes and prevention. Scandinavian Journal of Infectious Disease 32(6): 587-595.
  5. Leonard A Mermel1, Jennifer M Cartony, Pauline Covington, Gail Maxey, Dan Morse (2011) Methicillin-Resistant Staphylococcus aureus (MRSA) Colonization at Different Body Sites: A Prospective, Quantitative Analysis. Journal of Clinical Microbiology.
  6. von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal Carriage As a Source of Stapylococcus Aureus Bacteremia. New England Journal of Medicine 344 (1): 11-16.
  7. Yano K, Minoda Y, Sakawa A, Kuwano Y, Kondo K, Fukushima W, Tada K (2009) Positive Nasal Culture of Methicillin-resistant Staphylococcus aureus (MRSA) is a Risk Factor for Surgical Site Infection in Orthopedics. Acta Orthopaedica, 80(4).

Impact of Decolonization Therapy on HAI’s

  1. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U, Widmer AF (2008) Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infection Control and Hospital Epidemiology 29(6): 510-516.
  2. Sandri AM, Dalarosa MG, Alcantara LR, Elias LS, Zavascki AP (2006) Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: Role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infection Control and Hospital Epidemiology 27(2): 185-187.
  3. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, Kiss A (2007) Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin resistant Staphylococcus colonization. Clinical Infectious Diseases 44: 178-185.
  4. Dupeyron C, Campillo B, Richardet JP, Soussy CJ (2006) Long term efficacy of mupirocin in the prevention of infections with methicillin resistant Staphylococcus aureus in a gastroenterology unit. Journal of Hospital Infection 63: 385-392.
  5. van Rijen MM, Kluytmans JA (2008) New approaches to prevention of staphylococcal infection in surgery. Current Opinions in Infectious Disease 21(4): 380-384.
  6. Walsh E, Greene L, Kirshner R (2011) Staphylococcus aureus Wound Infections After Cardiothoracic Surgery. Arch Intern Med 171(1): 69-73.
  7. Fraser T, Fatica C, Scarpelli M, Arroliga A, Guzman J, Shrestha N, Hixson E, Rosenblatt M, Gordon S, Procop W (2010) Decrease in Staphylococcus aureus Colonization and Hospital Acquired Infection in a Medical Intensive Care Unit after Institution of an Active Surveillance and Decolonization Program. Infection Control and Hospital Epidemiology 31(8): 779-783.
  8. Rijen M, Bonten M, Wenzel R, Kluytmans J (2008) Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systemic review. Journal of Antimicrobial Chemotherapy 61: 254-261.
  9. Sandri A, Dalarosa M, Alcantara L, Elias L, Zavascki A (2006) Reduction in Incidence of Nosocomial Methicillin-Resistant Staphylococcus aureus (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA. Infection Control and Hospital Epidemiology 27(2): 185-187.